All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.
During the Acute Leukemia Forum (ALF) 2021, the ALL Hub spoke to Stephan A. Grupp, Children’s Hospital of Philadelphia, Philadelphia, US. We asked, Why should CAR T-cell therapy be used earlier in ALL?
Why should CAR T-cell therapy be used earlier in ALL?
In this video, Grupp outlines what groups of patients with ALL could benefit from earlier treatment with CAR T-cell infusions.
What’s the latest innovation in CAR-T therapy? Fast-off, dual targeting, and other new tricks
During the 2020 Annual Meeting of the Society of Hematologic Oncology (SOHO), the ALL Hub was pleased to speak to Martin Pule, University College London,...
What are the recent advances in immunotherapy for adult patients with ALL?
During the Acute Leukemia Forum (ALF) 2021, the ALL Hub spoke to Ibrahim T. Aldoss, City of Hope Comprehensive Cancer Center, Duarte, US. We asked, What are the recent...
Subscribe to get the best content related to ALL delivered to your inbox